Presentation is loading. Please wait.

Presentation is loading. Please wait.

1 9. Mitgliederversammlung CONELIS e.V. 18.10.2013.

Similar presentations


Presentation on theme: "1 9. Mitgliederversammlung CONELIS e.V. 18.10.2013."— Presentation transcript:

1 1 9. Mitgliederversammlung CONELIS e.V

2 Agenda 2 13:00Introduction New Members, VotingAstrid Schott 13:20Welcome and introduction roundAstrid Schott, all 13:40Election New CONELIS Board Introduction candidates Election Talk of the New Chairperson of the board Strategy Meeting 2014 Michael Hildebrand 14:15Conelis Questionnaire ResultsMichael Hildebrand 15:15Break 15:45BudgetChristian Wolf 16:00Conelis 5-year CelebrationMichael Hildebrand 16:30Product Development Group Result of Customer Interviews Next Steps Astrid Schott 17:00Conelis Participation in Meetings 2014Michael Hildebrand MiscellaneousAll 18:00DinnerAll

3 3 New Members

4 Agenda 4 13:00Introduction New Members, VotingAstrid Schott 13:20Welcome and introduction roundAstrid Schott, all 13:40Election New CONELIS Board Introduction candidates Election Talk of the New Chairperson of the board Strategy Meeting 2014 Michael Hildebrand 14:15Conelis Questionnaire ResultsMichael Hildebrand 15:15Break 15:45BudgetChristian Wolf 16:00Conelis 5-year CelebrationMichael Hildebrand 16:30Product Development Group Result of Customer Interviews Next Steps Astrid Schott 17:00Conelis Participation in Meetings 2014Michael Hildebrand MiscellaneousAll 18:00DinnerAll

5 Aus der Satzung….. Der Vorstand im Sinne des § 26 BGB besteht aus: – dem Vorsitzenden, dem stellvertretenden Vorsitzenden und dem Schatzmeister. – Beisitzern, die durch den Vorstand berufen werden können. Der Vorstand vertritt den Verein gerichtlich und außergerichtlich durch wenigstens zwei Mitglieder des Vorstands, darunter der Vorsitzende oder der stellvertretende Vorsitzende. Der Vorstand wird von der Mitgliederversammlung für die Dauer von 2 Jahren gewählt. Die Wiederwahl der Vorstandsmitglieder ist möglich. Der Vorsitzende ist nur einmalig in direkter Folge wieder wählbar. Die jeweils amtierenden Vorstandsmitglieder bleiben nach Ablauf ihrer Amtszeit im Amt, bis Nachfolger gewählt sind. Das Amt eines Vorstandsmitgliedes endet: – durch Ablauf der Amtszeit- mit der Niederlegung des Amtes durch schriftliche Mitteilung an den Vorstand, – durch Abberufung seitens der Mitgliederversammlung (einfache Mehrheit) oder – wenn das Vorstandsmitglied nicht mehr Mitglied des Vereins ist. 5

6 CONELIS SURVEY 2013 Members‘ Meeting Berlin

7 Survey

8 8 Other:

9 Survey

10 10

11 Survey

12 Survey Other:

13 Survey D:

14 Survey

15 Survey

16 Survey

17 What kind of CONELIS activities would you like to contribute to? 17 No *Topic Comments 3 + 6?/ no time/ no comment Depends on options, no clear suggestions right now/ currently no time/currently none 6Expertise relatedImprovement of the medical chemistry platform/ medical devices, RA and clinical/ medical devices / preclinical development / complete clinical trial development support / business projects 5Conference attendance (3) Conference attendance / participation in scientific meetings / talks on conferences on medical device + VD topics 3Booth duty/events Help in organizing special events / social events / booth duty 3SeminarsWorkshops - seminars on selected aspects in Pharma R&D led by Conelis or having a strong Conelis touch / organization of workshop / seminars, conferences but not direct BD activities 2Networking (external) Representative of Conelis in Bio-Deutschland/the existing regional collaboration with BioTop etc should be expanded to other organizers with visibility beyond Berlin-Brandenburg 1Strategy discussions 1Product development *of members commenting

18 Survey

19 Survey

20 Survey

21 Survey

22 Survey

23 Survey

24 Survey

25 Survey

26 26 Conelis Members should do more of the following: No *Topic Comments 7Interaction interacting with one another, too much top down driven right now / develop Conelis group feeling through more informal networking (Stammtisch)/ direct interaction / information on their expertise (2)/contact each other/participate in meetings 4Projects Discussion about interesting projects/look for synergies in the “areas of expertise”/involve other members in projects/collaborative projects 4 Marketing, BD help with staffing and organizing congresses and meetings/ active search for projects/more external presence like newsletter etc/ promotion of services 3 ( 2 external 1 Internal) Seminars Own medical scientific seminars on selected topics (eg MD reimbursement, clinical trials pharma vc. MD, reg. requirements Pharma vs. MD, post market clinical follow up, principles of risk management, tools of due diligence…/workshop, seminars on selected aspects in pharma R&D led by Conelis or having a strong Conelis touch/internal seminars once or twice a year 2 other Bring new ideas into the association/ Take advantage of member network *No of members commenting, 10 members had no comment, 1 of them “too early as recently joined”

27 The contact persons/board members should do more of the following: 27 No of members commenting Topic Comments 7Fine as is 2Contact PersonsRegular meetings or TCs / contact persons should organize at least 1 meeting in area of expertise per year and join forces for seminars or trainings 2Informationinformation / regular update on projects of Conelis members 1Seminarscontact persons should …. join forces for seminars/trainings 1Marketing/BDPromotion of services 12 members had no comment

28 The following topic(s) should be covered at the next members’ meeting/ strategy meeting (please specify) 28 NoMMStMTopicComments 51Marketing/ BD Improvement of the visibility of CONELIS/ reassessing of the topic “CROs as clients”/brainstorming for a re-newed web presence / presence at scientific meetings? / realize a real 1-stop-shop from pre-clinics to market access and joint cooperation for a “cat walk” of the complete CONELIS group / Business development 32ProductsMore clear definition of the CONELIS “Products”/ Conelis Product Development/definition of the CONELIS “Products” 21InformationShort verbal presentation of consultancy projects members are involved in/ statistics of projects coming through Conelis to the members, i.e. efficiency of outreach efforts by Conelis 2InteractionInteraction between members / collaborative projects 1NetworkingDiscussion about a network with other groups/institutions 1Planning of the next strategy meeting 11Competence centers Creation of competence centers (ie clinical trials, trial conduct, medical writing, statistical expertise center…) 1RegulationNew MD regulation * Of members commenting, 11 members had no comment, MM Members´meeting, StM Strategy Meeting

29 Additional issues/comments/suggestions 29 No of members commenting Topic Comments 5Question- naire related Questions 17, 18, 26 could not be answered due to bugs in document/ item 30:never/ Q12: response don’t know, have no information have never attended, Q 13 don’t know, have no information have never attended/ have never attended strategy meeting, rated them 100% as I could not leave them blank/ what is meant by “support”? Being present at the booth of CONELIS or making other colleagues, clients and participants at other meetings aware of CONELIS, which I do, Q9: difficult living outside Germany, Q12: what do you mean? Q19-21 not applicable, 25: good to know each other and the expertise but what is intense contact? 3Fine as isSo far so good/continue your excellent work!/super idea the survey! 1 MeetingMeeting outside Berlin 1Marketing/ BD We used to present CONELIS at MEDICA, the information material need more clear statements on CONELIS products, we used to present the current material at MEDICA and always got understanding questions

30 Action Issues from Survey 30 Topic:Information on activities Proposal: Each Contact Person (CP) should give some written info on some important activities in the respective group to be placed in the CONELIS Newsletter Joint TCs (at least twice a year) of Board and CPs

31 Action Issues from Survey 31 Topic:Promotion of services Task Force:Who ? Topic:Information on fields of expertise Verbal presentation on projects members are involved in - Use individual profile description on CONELIS homepage - Establish informal round table ? Task force:Who ?

32 Topics for Strategy Meeting 32 How to improve the visibility of CONELIS ? Is there a need and an option to establish a One-stop-shop for our customers ? How to facilitate/generate more collaborative projects ?

33 BREAK 33

34 Agenda 34 13:00Introduction New Members, VotingAstrid Schott 13:20Welcome and introduction roundAstrid Schott, all 13:40Election New CONELIS Board Introduction candidates Election Talk of the New Chairperson of the board Strategy Meeting 2014 Michael Hildebrand 14:15Conelis Questionnaire ResultsMichael Hildebrand 15:15Break 15:45BudgetChristian Wolf 16:00Conelis 5-year CelebrationMichael Hildebrand 16:30Product Development Group Result of Customer Interviews Next Steps Astrid Schott 17:00Conelis Participation in Meetings 2014Michael Hildebrand MiscellaneousAll 18:00DinnerAll

35 Budget – Einnahmen 35 IstPlan Beitrag OM7.984,50500,00 - davon Aufnahmegebühr ,00 Beitrag FM6.250,00 - davon Aufnahmegebühr ,00 - davon Beiträge/Gebühren ,00 Spende500,00 Zinsen19,355,00 Gesamt14.753,85505,00 Plan: budgetierte Einnahmen Aufnahme von 2 ordentlichen Mitgliedern (Aufnahmegebühr erlassen) übliche Zinsen auf DKB-Konto Einnahmeplanung Mai 2013: € ,50 vs ,85 im Nov 2013

36 Budget – Ausgaben IstPlan Externe Veranstaltungen-2.095, ,00 Werbemittel (inkl. Webseite)-1.880,77 Geschäftsstelle-1.071,00-357,00 Interne Veranstaltungen-443, ,00 Gesamt-5.490, ,00 36 Plan: budgetierte Ausgaben Sponsoring eines Conelis-Teilnehmers bei der BioEurope (Wien, Nov 2013) Zahlungen für 3 Monate Betreuung der Geschäftsstelle MV und Abendveranstaltung; GLS-Sprachenschule (Okt 2013) Ausgabenplanung Mai 2013: € ,00 vs 9.442,73 im Nov 2013 (beide Beträge ohne im Mai vorgeschlagene Rückstellung von € für 5er-Jubiläum)

37 Budget – Saldo 2013 und Ausblick Einnahmen ,85 Ausgaben ,73 Saldo ,12 37 Ausblick neue ordentliche Mitglieder Ausfall von 2 Fördermitgliedern: BioScientia und NisiPharm Geplante Einnahmen  32 ordentliche Mitglieder x € 250 = €  6 Fördermitglieder = € Geplante Ausgaben  ca. € (ohne 5er Jubiläum) Saldo  ca. € 5.250

38 5 - year celebration 38 Type of event ? Based on survey an event with external guests either in combination with science or art was favourite. Who will be on the team to organize the event?

39 Agenda 39 13:00Introduction New Members, VotingAstrid Schott 13:20Welcome and introduction roundAstrid Schott, all 13:40Election New CONELIS Board Introduction candidates Election Talk of the New Chairperson of the board Strategy Meeting 2014 Michael Hildebrand 14:15Conelis Questionnaire ResultsMichael Hildebrand 15:15Break 15:45BudgetChristian Wolf 16:00Conelis 5-year CelebrationMichael Hildebrand 16:30Product Development Group Result of Customer Interviews Next Steps Astrid Schott 17:00Conelis Participation in Meetings 2014Michael Hildebrand MiscellaneousAll 18:00DinnerAll

40 Product Development Group Interdisciplinary services in “Current Services A-Z” – Due diligence* – Portfolio Assessment – “Preclinical development”* – R&D Strategies What should be developed into a CONELIS Product? *have been conducted by Conelis teams 40

41 Conelis Product Development Group Conrad- Kintzel- Lampe –Matzen –Schott (+ Hildebrand, Wolf) What could reasonable CONELIS products be – “Zweitmeinung” – “2 nd opinion”  Analyse the need – Customer Interviews  partly done – Competitor analysis Clarify liability issues. – “Bietergemeinschaft”  – Other forms of organization/company Product Specification Testrun 41

42 Customer Interviews “2 nd opinion” Demographics 42 PlannedDone Pharma/Biotech115 Venture Capital21 Medical Device- Academia- Company Size (VC)

43 “I would like to have a 2 nd opinion for….” Customers were asked the open question,if they ever had thought, they would like to have a 2 nd opinion (if>1 numbers in brackets) – what was the topic? : Clinical development plans (3), Study design CMC data Regulatory framework in different (exotic) regions, special regulations Health Economics Market Development in the future (2) (depending on health policies and generic competition) Produkt evaluation (2), „Wirtschaflichkeisberechnung“, „Potential“, Business-case Partnering opportunities, risks Launch strategies, Marketing Market access/reimbursement (2) Further comments : „Zweitmeinung“ ist ein super Name! So was gibt es evt. für Due Diligence- sonst jedoch noch nicht Zweitmeinung wurde schon eingeholt wenn: – man sich selber nicht gut fühlt mit der 1. Meinung – wenn 1. Meinung nicht der eigenen Position entspricht („paßt nicht in meine Strategie“) – man den Experten der 1. Meinung nicht voll vertraut. Das ist ein sequentieller Prozess – Entscheidung für Zweitmeinung fällt nach der Ersten Meinung! 43

44 What is you potential interest in a “2 nd opinion” concerning the following topics (1 no interest to 5 very high interest) Topic12345 Decision to move a product into the next phase of development (ie preclinical to clinical testing) Milestone planning (preclinical or clinical development plans) Concerning documents (IB, protocols or reports) Concerning internal decisions (portfolio assessment, termination of projects) Support of in-licensing (due diligence, as 2 nd opinion, not due diligence itself) 44. External validation is standard Clinical Development Clinical Dev., CMC Risks, strategy Study protocols, dossier 2x Not applicable For small companies

45 Team “2 nd opinion” Customers were asked the open question, which characteristics they would deem necessary for team members in a “2 nd opinion team/Sparringboard”: Erfahrung im Gebiet, wirklicher Experte (5) Sind auf der Höhe der aktuellen Entwicklungen Netzwerke /aktuelle Kontakte Industry background Offenheit und Kreativität Guter Mix- Senior + Querdenker/Methodiker Können Wirtschaftlichkeit einschätzen 45 NeinJaComment, or undecided Would you appreciate if experts from Industry would be part of the team? 14 1 “depending on Question/ problem, could be a chance”, ” I assume Conelis members to have an industrial background”

46 Please rate characteristics for an interdisciplinary team giving a 2 nd opinion (1 not important, 5 very important) 46 Topic12345 Seniority (was defined differently by interview partners – age not important, experience) Continuity (always same team members Flexibility – team members according to need Always the same person organizing the “2 nd opinion” Independence of experts (no experts from industry) If Quality ok Should be part of the team If confidentiality is guaranteed

47 Costs – Example 1 Participants were asked what the prize for a typical “2 nd opinion” should be Consultancy Fees (without travel costs, costs for room…) in T€: Sparringboard Development Plan Team with 5 interdisciplinary experts: Pharmacology Toxicology Clinical development Market expert Regulatory expert 1 day review of development plan and IB per consultant, product is a small molecule phase Ib, 4 hours discussion with company Including Report *“Hochrechnung marktüblicher Tagessätze” of max. 20T€ 0 T€ *

48 Participants were asked what the prize for a typical “2 nd opinion” should be Consultancy fees: Study protocol, no interest in IB review 0 0,8-1T€ Costs – Example Document Review Review Investigator brochure before Phase I 4 experts: Toxicology Pharmacology Clinical development Regulatory Input in writing, document has 30 pages (2) According to daily rates

49 Next Steps 1.Brainstorming 2.Product taskforce identified 3.Need analysis 1.Customer interviews - continue 2.Competitor analyses 4.Product specification 5.Product Development and “Testrun” 49

50 Agenda 50 13:00Introduction New Members, VotingAstrid Schott 13:20Welcome and introduction roundAstrid Schott, all 13:40Election New CONELIS Board Introduction candidates Election Talk of the New Chairperson of the board Strategy Meeting 2014 Michael Hildebrand 14:15Conelis Questionnaire ResultsMichael Hildebrand 15:15Break 15:45BudgetChristian Wolf 16:00Conelis 5-year CelebrationMichael Hildebrand 16:30Product Development Group Result of Customer Interviews Next Steps Astrid Schott 17:00Conelis Participation in Meetings 2014Michael Hildebrand MiscellaneousAll 18:00DinnerAll

51 Conelis Participation in Meetings 2013/2014 Bio-Europe Wien 2013 Deutsche BiotechnologieTage April 9 and 10 in Hamburg DIA Europe Wien März International Conference of Pharmaceutical Medicine (ICPM) 2014: Berlin März 51

52 Agenda 52 13:00Introduction New Members, VotingAstrid Schott 13:20Welcome and introduction roundAstrid Schott, all 13:40Election New CONELIS Board Introduction candidates Election Talk of the New Chairperson of the board Strategy Meeting 2014 Michael Hildebrand 14:15Conelis Questionnaire ResultsMichael Hildebrand 15:15Break 15:45BudgetChristian Wolf 16:00Conelis 5-year CelebrationMichael Hildebrand 16:30Product Development Group Result of Customer Interviews Next Steps Astrid Schott 17:00Conelis Participation in Meetings 2014Michael Hildebrand MiscellaneousAll 18:00DinnerAll

53 Miscellaneous BIO EUROPE In Vienna (4 – 6 Nov 2013). Medtech within CONELIS – Currently Lampe, Zimmermann and Zanker are working in the Medical Device area – proposal how the Medtech area can be strengthened within CONELIS – Extra group/division ? Outcome research and Pricing within Conelis Membership “Bio Deutschland”, fee around 1000€ a year – Should be decided by vote 53

54 BACKUPS 54

55 Google analytics compared to last year min

56 Pageviews by content 56

57 57


Download ppt "1 9. Mitgliederversammlung CONELIS e.V. 18.10.2013."

Similar presentations


Ads by Google